NCT00207155已完成1 期
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 110
- 试验地点
- 1
- 主要终点
- Prediction of response to Erbitux in subjects with metastatic colorectal cancer
研究概览
简要总结
The purpose of this study is to predict response to Erbitux as a single agent in patients with metastatic colon cancer
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Measurable disease Tumor available for biopsies. Life expectancy of at least 3 months.
排除标准
- •Known or documented brain metastases prior to Cetuximab therapy.
研究组 & 干预措施
A
Experimental
干预措施: Cetuximab (Drug)
结局指标
主要结局
Prediction of response to Erbitux in subjects with metastatic colorectal cancer
次要结局
- Radiographic Response
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung CarcinomaCarcinoma, Non-Small-Cell LungNeoplasm MetastasisNCT00207116Eli Lilly and Company120
Unknown
不适用
Study of Methotrexate Given to Juvenile Idiopathic Arthritis Patients Based on Pharmacogenomics and PharmacometricsJuvenile Idiopathic ArthritisNCT03006991Guangzhou Women and Children's Medical Center100
已完成
2 期
Palbociclib and Cetuximab in Metastatic Colorectal CancerCancer of the ColonColon NeoplasmsColonic CancerNeoplasms, ColonicColon CancerNCT03446157UNC Lineberger Comprehensive Cancer Center24
已完成
2 期
Biomarker Directed Treatment in Metastatic Colorectal CancerMetastatic Colorectal CancerNCT01703390Arbeitsgemeinschaft medikamentoese Tumortherapie47
已完成
2 期
Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)OsteoarthritisNCT00242489Organon and Co1,167